PapersFlow Research Brief
Neurological Disease Mechanisms and Treatments
Research Guide
What is Neurological Disease Mechanisms and Treatments?
Neurological Disease Mechanisms and Treatments is a research cluster examining chronic cerebral hypoperfusion and its links to neurodegenerative diseases, vascular cognitive impairment, white matter lesions, and oxidative stress, alongside experimental models, glial activation, memory impairment, and neuroprotective effects of compounds.
The field includes 50,657 papers on cerebral hypoperfusion's role in neurological disorders. Studies cover animal models of ischemia and diagnostic criteria for conditions like mild cognitive impairment due to Alzheimer's disease and vascular dementia. Research also addresses glial interactions and amyloid imaging in disease mechanisms.
Topic Hierarchy
Research Sub-Topics
Chronic Cerebral Hypoperfusion Models
This sub-topic develops and validates animal models like bilateral carotid occlusion to mimic human hypoperfusion. Researchers characterize blood flow reductions and cognitive deficits.
Vascular Cognitive Impairment
This sub-topic examines cognitive decline from cerebrovascular disease, distinct from Alzheimer's. Researchers study diagnostic criteria, neuroimaging biomarkers, and risk factors.
White Matter Lesions in Aging
This sub-topic investigates hyperintensities on MRI as markers of small vessel disease and hypoperfusion. Researchers link lesions to gait disturbance, executive dysfunction, and progression.
Glial Activation in Neurodegeneration
This sub-topic explores microglial and astrocytic responses to hypoperfusion-induced injury. Researchers study neuroinflammation markers and their dual protective/detrimental roles.
Oxidative Stress in Cerebral Hypoperfusion
This sub-topic analyzes ROS generation, antioxidant defenses, and lipid peroxidation from ischemia. Researchers test compounds mitigating oxidative damage in hypoperfusion models.
Why It Matters
Diagnostic guidelines from Albert et al. (2011) in 'The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease' enable early identification of predementia Alzheimer's phases, aiding timely interventions in 16 patients showing marked Pittsburgh Compound-B retention via PET imaging as reported by Klunk et al. (2004). Hachinski et al. (1975) in 'Cerebral Blood Flow in Dementia' measured regional cerebral blood flow in 24 dementia patients, distinguishing multi-infarct from primary degenerative types based on an Ischemic Score, which supports targeted vascular treatments. Zea Longa et al. (1989) developed a rat model of reversible middle cerebral artery occlusion, used in 7351 citations to study infarction and neuroprotection, advancing preclinical testing of therapies for stroke-related cognitive impairment.
Reading Guide
Where to Start
'The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease' by Albert et al. (2011), as it provides foundational diagnostic criteria for a key predementia phase, offering clear entry into disease mechanisms and assessment.
Key Papers Explained
Albert et al. (2011) in 'The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease' builds diagnostic foundations that Hyman et al. (2012) extends in 'National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease' with updated neuropathologic evaluations recognizing pre-clinical stages. Román et al. (1993) in 'Vascular dementia' complements these by establishing vascular dementia criteria, linking to Hachinski et al. (1975) 'Cerebral Blood Flow in Dementia' which differentiates dementia types via blood flow measurements. Guerreiro et al. (2012) in 'TREM2 Variants in Alzheimer's Disease' adds genetic risk insights relevant to both Alzheimer's and vascular mechanisms.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes chronic cerebral hypoperfusion models, glial activation, and oxidative stress in neurodegenerative diseases, with no recent preprints or news indicating ongoing focus on experimental animal models and neuroprotective compounds from the core 50,657 papers.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The diagnosis of mild cognitive impairment due to Alzheimer's ... | 2011 | Alzheimer s & Dementia | 9.8K | ✕ |
| 2 | Reversible middle cerebral artery occlusion without craniectom... | 1989 | Stroke | 7.4K | ✓ |
| 3 | Astrocyte–endothelial interactions at the blood–brain barrier | 2005 | Nature reviews. Neuros... | 5.4K | ✕ |
| 4 | Vascular dementia | 1993 | Neurology | 4.9K | ✕ |
| 5 | Imaging brain amyloid in Alzheimer's disease with Pittsburgh C... | 2004 | Annals of Neurology | 4.4K | ✕ |
| 6 | Consensus guidelines for the clinical and pathologic diagnosis... | 1996 | Neurology | 4.0K | ✕ |
| 7 | Preparation of separate astroglial and oligodendroglial cell c... | 1980 | The Journal of Cell Bi... | 3.9K | ✓ |
| 8 | Cerebral Blood Flow in Dementia | 1975 | Archives of Neurology | 3.2K | ✕ |
| 9 | National Institute on Aging–Alzheimer's Association guidelines... | 2012 | Alzheimer s & Dementia | 3.0K | ✓ |
| 10 | <i>TREM2</i> Variants in Alzheimer's Disease | 2012 | New England Journal of... | 2.9K | ✓ |
Frequently Asked Questions
What criteria define mild cognitive impairment due to Alzheimer's disease?
Albert et al. (2011) in 'The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease' established criteria for the symptomatic predementia phase of Alzheimer's disease. These include two sets of recommendations developed by a National Institute on Aging-Alzheimer's Association workgroup. The guidelines focus on cognitive symptoms and biomarker evidence.
How is reversible middle cerebral artery occlusion modeled in rats?
Zea Longa et al. (1989) in 'Reversible middle cerebral artery occlusion without craniectomy in rats' tested methods for inducing infarction in the right middle cerebral artery territory using extracranial vascular occlusion. Preliminary studies involved 60 anesthetized rats to develop a simple, noninvasive model of reversible regional cerebral ischemia. The model produces consistent infarcts for studying ischemia mechanisms.
What role do astrocytes play at the blood-brain barrier?
Abbott et al. (2005) in 'Astrocyte–endothelial interactions at the blood–brain barrier' describe interactions regulating barrier function. Astrocytes influence endothelial tight junctions and transport processes. These interactions are central to maintaining blood-brain barrier integrity in neurological diseases.
What are the diagnostic criteria for vascular dementia?
Román et al. (1993) in 'Vascular dementia' provide criteria developed by the Neuroepidemiology Branch of the National Institute of Neurological Disorders and Stroke. The guidelines address needs for reliable diagnosis in clinical and research settings. They emphasize clinical features and applicability across various contexts.
How is brain amyloid imaged in Alzheimer's disease?
Klunk et al. (2004) in 'Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B' report the first human PET study using Pittsburgh Compound-B in 16 mild AD patients and 9 controls. AD patients showed marked retention in cortical areas compared to controls. This tracer enables in vivo amyloid detection.
What variants increase Alzheimer's disease risk?
Guerreiro et al. (2012) in 'TREM2 Variants in Alzheimer's Disease' identify heterozygous rare variants in TREM2 associated with increased Alzheimer's risk. The study links these genetic factors to disease susceptibility. Findings were funded by Alzheimer's Research UK and others.
Open Research Questions
- ? How does chronic cerebral hypoperfusion contribute to white matter lesions and glial activation in vascular cognitive impairment?
- ? What are the precise neuroprotective mechanisms of compounds against oxidative stress in hypoperfusion-induced memory impairment?
- ? Which experimental models best replicate human neurodegenerative diseases linked to cerebral hypoperfusion?
- ? How do TREM2 variants interact with vascular factors in Alzheimer's disease progression?
- ? What blood flow patterns distinguish multi-infarct dementia from primary degenerative dementia?
Recent Trends
The field maintains 50,657 works with no specified 5-year growth rate; highly cited papers from 1975 to 2012, such as Hachinski et al. with 3178 citations on cerebral blood flow and Guerreiro et al. (2012) with 2949 on TREM2 variants, reflect sustained interest in vascular and genetic mechanisms of dementia, with no recent preprints or news coverage.
1975Research Neurological Disease Mechanisms and Treatments with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Neurological Disease Mechanisms and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers